ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Xingpeng Shi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5111105563. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper

Papers 1

Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells. Co-author DOI 10.1016/j.bmcl.2020.127725 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yanping Li · 1 shared paper, 2021 · strength 0.17
- Paper Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase … DOI 10.1016/j.bmcl.2020.127725 ↗
Ying Wang · 1 shared paper, 2021 · strength 0.17
- Paper Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase … DOI 10.1016/j.bmcl.2020.127725 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.